Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 375

1.

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.

Abbott C, Bustillo J.

Curr Opin Psychiatry. 2006 Mar;19(2):135-9. Review.

PMID:
16612192
[PubMed - indexed for MEDLINE]
2.

Proton magnetic resonance spectroscopy of the human brain in schizophrenia.

Deicken RF, Johnson C, Pegues M.

Rev Neurosci. 2000;11(2-3):147-58. Review.

PMID:
10718151
[PubMed - indexed for MEDLINE]
3.

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B.

Schizophr Res. 2005 Mar 1;73(2-3):153-7.

PMID:
15653258
[PubMed - indexed for MEDLINE]
4.

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.

Yoo SY, Yeon S, Choi CH, Kang DH, Lee JM, Shin NY, Jung WH, Choi JS, Jang DP, Kwon JS.

Schizophr Res. 2009 Jun;111(1-3):86-93. doi: 10.1016/j.schres.2009.03.036. Epub 2009 Apr 29.

PMID:
19406622
[PubMed - indexed for MEDLINE]
5.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
[PubMed - indexed for MEDLINE]
6.

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L, Canaran G, Rylett RJ, Neufeld RW.

Arch Gen Psychiatry. 1997 Oct;54(10):959-65.

PMID:
9337777
[PubMed - indexed for MEDLINE]
7.

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.

Heimberg C, Komoroski RA, Lawson WB, Cardwell D, Karson CN.

Psychiatry Res. 1998 Aug 26;83(2):105-15.

PMID:
9818736
[PubMed - indexed for MEDLINE]
8.

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T.

Schizophr Res. 2009 Mar;108(1-3):69-77. doi: 10.1016/j.schres.2008.11.014. Epub 2008 Dec 20.

PMID:
19097753
[PubMed - indexed for MEDLINE]
9.

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.

Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, Thompson RT.

Schizophr Bull. 1996;22(4):597-609.

PMID:
8938914
[PubMed - indexed for MEDLINE]
Free Article
10.

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls.

Steel RM, Bastin ME, McConnell S, Marshall I, Cunningham-Owens DG, Lawrie SM, Johnstone EC, Best JJ.

Psychiatry Res. 2001 May 30;106(3):161-70.

PMID:
11382538
[PubMed - indexed for MEDLINE]
11.

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ.

Am J Psychiatry. 2003 Dec;160(12):2231-3.

PMID:
14638596
[PubMed - indexed for MEDLINE]
12.

Decreased left frontal lobe N-acetylaspartate in schizophrenia.

Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW.

Am J Psychiatry. 1997 May;154(5):688-90.

PMID:
9137129
[PubMed - indexed for MEDLINE]
13.

A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.

Jang JH, Kwon JS, Jang DP, Moon WJ, Lee JM, Ha TH, Chung EC, Kim IY, Kim SI.

Am J Psychiatry. 2006 Jul;163(7):1202-7.

PMID:
16816225
[PubMed - indexed for MEDLINE]
14.

The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).

Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.

Pharmacopsychiatry. 2005 Sep;38(5):214-9.

PMID:
16189748
[PubMed - indexed for MEDLINE]
15.

MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.

Tunc-Skarka N, Weber-Fahr W, Hoerst M, Meyer-Lindenberg A, Zink M, Ende G.

Neuroimage. 2009 Nov 15;48(3):525-31. doi: 10.1016/j.neuroimage.2009.06.061. Epub 2009 Jun 30.

PMID:
19573608
[PubMed - indexed for MEDLINE]
16.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
[PubMed - indexed for MEDLINE]
17.

1 H-MR spectroscopy in ultra-high risk and first episode stages of schizophrenia.

Uhl I, Mavrogiorgou P, Norra C, Forstreuter F, Scheel M, Witthaus H, Ozgürdal S, Gudlowski Y, Bohner G, Gallinat J, Klingebiel R, Heinz A, Juckel G.

J Psychiatr Res. 2011 Sep;45(9):1135-9. doi: 10.1016/j.jpsychires.2011.02.004. Epub 2011 Mar 11.

PMID:
21397254
[PubMed - indexed for MEDLINE]
18.

Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.

Rowland L, Bustillo JR, Lauriello J.

Semin Clin Neuropsychiatry. 2001 Apr;6(2):121-30. Review.

PMID:
11296312
[PubMed - indexed for MEDLINE]
19.

N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.

Jakary A, Vinogradov S, Feiwell R, Deicken RF.

Schizophr Res. 2005 Jul 15;76(2-3):173-85. Epub 2005 Apr 15.

PMID:
15949650
[PubMed - indexed for MEDLINE]
20.

Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.

Omori M, Murata T, Kimura H, Koshimoto Y, Kado H, Ishimori Y, Ito H, Wada Y.

Psychiatry Res. 2000 May 15;98(3):155-62.

PMID:
10821998
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk